| Field | Row 1 |
|---|---|
| adsh | 0001178913-25-001205 |
| cik | 1534248 |
| name | CHEMOMAB THERAPEUTICS LTD. |
| sic | 2834 |
| countryba | IL |
| stprba | |
| cityba | TEL AVIV |
| zipba | 6158002 |
| bas1 | KIRYAT ATIDIM, BUILDING 7 |
| bas2 | |
| baph | 972-77-331-0156 |
| countryma | IL |
| stprma | |
| cityma | TEL AVIV |
| zipma | 6158002 |
| mas1 | KIRYAT ATIDIM, BUILDING 7 |
| mas2 | |
| countryinc | IL |
| stprinc | |
| ein | 813676773 |
| former | ANCHIANO THERAPEUTICS LTD. |
| changed | 20180906 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 20-F |
| period | 20241231 |
| fy | 2024 |
| fp | FY |
| filed | 20250404 |
| accepted | 2025-04-04 17:18:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | zk2532902_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001178913-25-001205 | 20241231 | Accrued Liabilities Current | 75000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001178913-25-001205 | 20231231 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Common Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Earnings Per Share Basic | 0.1210 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Earnings Per Share Basic | 0.1030 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Liabilities | 3427000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Liabilities And Stockholders Equity | 16964000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Net Cash Provided By Used In Investing Activities | 2297000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Nonoperating Income Expense | 794000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Operating Expenses | 28533000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Operating Lease Liability Noncurrent | 316000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Payments Of Stock Issuance Costs | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Payments Of Stock Issuance Costs | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Proceeds From Other Equity | 267000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Proceeds From Other Equity | 9868000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Proceeds From Sale Of Treasury Stock | 580000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Shares Outstanding | 232636700.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Shares Outstanding | 377132220.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period Value New Issues | 267000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period Value New Issues | 267000.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period Value New Issues | 9868000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20211231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stockholders Equity | -63819000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20221231 | Stockholders Equity | -1218000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Treasury Stock Reissued | 580000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Treasury Stock Reissued | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Treasury Stock Reissued | 1218000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Weighted Average Number Of Shares Outstanding Basic | 227589288.0000 | shares | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Assets Noncurrent | 924000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Assets | 16964000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Cash And Cash Equivalents At Carrying Value | 5545000.0000 | USD | 0 | us-gaap/2024 | Currency= U S D; | ||
| 0001178913-25-001205 | 20241231 | Cash And Cash Equivalents At Carrying Value | 1000.0000 | USD | 0 | us-gaap/2024 | Currency= X X X; | ||
| 0001178913-25-001205 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001178913-25-001205 | 20231231 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Common Stock Shares Authorized | 650000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Common Stock Shares Authorized | 4650000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Depreciation | 67000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Earnings Per Share Diluted | 0.0390 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Employee Related Liabilities Current | 490000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001178913-25-001205 | 20231231 | Income Taxes Received | 187000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20241231 | Income Taxes Received | 0.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20221231 | Increase Decrease In Accounts Payable Trade | 352000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Increase Decrease In Operating Lease Liability | 13000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 64000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Interest Received | 814000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20231231 | Net Cash Provided By Used In Financing Activities | 3504000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Income Loss | -27646000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Operating Lease Right Of Use Asset | 289000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Payments For Investment In Deposits | -19601000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20221231 | Payments To Acquire Property Plant And Equipment | 68000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Proceeds From Stock Options Exercised | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Research And Development Expense | 11327000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Restricted Cash Current | 76000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Restricted Cash Current | 76000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Shares Outstanding | -11640460.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period New Issues | 0.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20211231 | Stockholders Equity | 61466000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20211231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stock Issued During Period Value Share Based Compensation | 617000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Treasury Stock Reissued | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Weighted Average Number Of Diluted Shares Outstanding | 227589288.0000 | shares | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Weighted Average Number Of Shares Outstanding Basic | 359048638.0000 | shares | 4 | us-gaap/2024 | Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1) | ||
| 0001178913-25-001205 | 20231231 | Cash And Cash Equivalents At Carrying Value | 9292000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 9368000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Earnings Per Share Basic | 0.0390 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Earnings Per Share Diluted | 0.1030 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | General And Administrative Expense | 7078000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Income Tax Expense Benefit | -534000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Increase Decrease In Accounts Payable Trade | 150000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Increase Decrease In Accrued Liabilities | 45000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Interest Received | 972000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20231231 | Liabilities | 5154000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Income Loss | -27646000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Net Income Loss | -13945000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Operating Expenses | 14739000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Payments To Acquire Property Plant And Equipment | 3000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Prepaid Expense Noncurrent | 559000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231130 | Proceeds From Sale Of Treasury Stock | 580000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Research And Development Expense | 18381000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Retained Earnings Accumulated Deficit | -102623000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20211231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Shares Outstanding | 284094700.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period New Issues | 2576400.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Weighted Average Number Of Shares Outstanding Basic | 234998859.0000 | shares | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Profit Loss | -13945000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Additional Paid In Capital | 105675000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Additional Paid In Capital | 116160000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Assets Current | 20897000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Cash And Cash Equivalents At Carrying Value | 2574000.0000 | USD | 0 | us-gaap/2024 | Currency= I L S; | ||
| 0001178913-25-001205 | 20231231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001178913-25-001205 | 20241231 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Employee Related Liabilities Current | 874000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | General And Administrative Expense | 11556000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Increase Decrease In Operating Lease Liability | 35000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Liabilities Current | 3218000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Liabilities Noncurrent | 209000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Cash Provided By Used In Financing Activities | -808000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Net Cash Provided By Used In Investing Activities | 15879000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Cash Provided By Used In Operating Activities | -20370000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Net Cash Provided By Used In Operating Activities | -15386000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20241231 | Net Income Loss | -13945000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Operating Expenses | 25459000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Prepaid Expense Noncurrent | 385000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Proceeds From Stock Options Exercised | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Share Based Compensation | 3211000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Share Based Compensation | 1491000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20211231 | Stockholders Equity | 97639000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stockholders Equity | 101260000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20241231 | Stockholders Equity | -102623000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Shares Treasury Stock Reissued | 11640460.0000 | shares | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Share Based Compensation | 3211000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Share Based Compensation | 3211000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20231231 | Weighted Average Number Of Diluted Shares Outstanding | 234998859.0000 | shares | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Treasury Stock Reissued | -1218000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Weighted Average Number Of Diluted Shares Outstanding | 359048638.0000 | shares | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stockholders Equity | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stockholders Equity | 13537000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Accrued Liabilities Current | 1563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Cash And Cash Equivalents At Carrying Value | 525000.0000 | USD | 0 | us-gaap/2024 | Currency= I L S; | ||
| 0001178913-25-001205 | 20241231 | Common Stock Shares Issued | 377132220.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Deposits Assets Current | 10492000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Deposits Assets Current | 8195000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Employee Related Liabilities Current | 823000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -13945000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Income Taxes Received | 351000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20241231 | Increase Decrease In Accrued Liabilities | -1860000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Increase Decrease In Employee Related Liabilities | 907000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Cash Provided By Used In Investing Activities | 19533000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Operating Lease Liability Current | 76000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Payments Of Stock Issuance Costs | 1218000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Proceeds From Sale Of Treasury Stock | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Proceeds From Stock Options Exercised | 143000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Property Plant And Equipment Net | 250000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period New Issues | 0.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20221231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period Value New Issues | 2924000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20231231 | Stockholders Equity | -88678000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Stockholders Equity | 116160000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Shares Stock Options Exercised | 1970000.0000 | shares | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stock Issued During Period Value Share Based Compensation | 617000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Treasury Stock Reissued | -1218000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Treasury Stock Reissued | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Treasury Stock Reissued | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Accounts Payable Trade Current | 666000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Cash And Cash Equivalents At Carrying Value | 6071000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20211231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 15241000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Common Stock Shares Issued | 284094700.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Depreciation | 58000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | General And Administrative Expense | 3412000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Increase Decrease In Accounts Payable Trade | -1172000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Increase Decrease In Employee Related Liabilities | -737000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Interest Received | 1463000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20231231 | Liabilities And Stockholders Equity | 22151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Liabilities Current | 4838000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Liabilities Noncurrent | 316000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Net Income Loss | -24221000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20241231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20241231 | Operating Lease Liability Current | 115000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Payments For Investment In Deposits | -15882000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20241231 | Payments For Investment In Deposits | -2297000.0000 | USD | 4 | 0001178913-25-001205 | |||
| 0001178913-25-001205 | 20221231 | Profit Loss | -27646000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Property Plant And Equipment Net | 303000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Retained Earnings Accumulated Deficit | -88678000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Shares Outstanding | 377132220.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period New Issues | 51458000.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period New Issues | 93037520.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20231231 | Accounts Payable Trade Current | 516000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Assets Current | 16040000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Assets Noncurrent | 1254000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Cash And Cash Equivalents At Carrying Value | 0.0000 | USD | 0 | us-gaap/2024 | Currency= X X X; | Less than 1 thousand | |
| 0001178913-25-001205 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1645000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -3221000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Employee Related Liabilities Current | 531000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001178913-25-001205 | 20231231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -24221000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Increase Decrease In Accrued Liabilities | 2823000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -903000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Net Cash Provided By Used In Financing Activities | 9868000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Net Cash Provided By Used In Operating Activities | -23611000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Net Income Loss | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Nonoperating Income Expense | 353000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Prepaid Expense And Other Assets Current | 1037000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Prepaid Expense And Other Assets Current | 1698000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Profit Loss | -24221000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 17000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20211231 | Shares Outstanding | 228090300.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period New Issues | 0.0000 | shares | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period Value New Issues | 9868000.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Shares Treasury Stock Reissued | -11640460.0000 | shares | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Share Based Compensation | 1491000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Share Based Compensation | 1491000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20241231 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Stock Options Exercised | 143000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Stock Options Exercised | 143000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Net Income Loss | -24221000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 487000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Accrued Liabilities Current | 3423000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Accrued Liabilities Current | 74000.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001178913-25-001205 | 20231231 | Assets | 22151000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Cash And Cash Equivalents At Carrying Value | 6718000.0000 | USD | 0 | us-gaap/2024 | Currency= U S D; | ||
| 0001178913-25-001205 | 20221231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 13596000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 6147000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -4228000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Depreciation | 53000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Earnings Per Share Diluted | 0.1210 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -28180000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Income Tax Expense Benefit | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Increase Decrease In Employee Related Liabilities | 51000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Increase Decrease In Operating Lease Liability | -11000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Nonoperating Income Expense | 1238000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Operating Lease Liability Noncurrent | 209000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Operating Lease Right Of Use Asset | 392000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Proceeds From Other Equity | 2924000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Proceeds From Sale Of Treasury Stock | 0.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20221231 | Research And Development Expense | 16977000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 392000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20241231 | Share Based Compensation | 617000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Shares Outstanding | 284094700.0000 | shares | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period Value New Issues | 2924000.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20231231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20241231 | Stock And Warrants Issued During Period Value New Issues | 0.0000 | USD | 4 | 0001178913-25-001205 | Equity Components= Treasury Stock Common; | ||
| 0001178913-25-001205 | 20211231 | Stockholders Equity | -36173000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001178913-25-001205 | 20221231 | Stockholders Equity | 36223000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stockholders Equity | 16997000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001178913-25-001205 | 20231231 | Stockholders Equity | 105675000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001178913-25-001205 | 20221231 | Stock Issued During Period Value Treasury Stock Reissued | 0.0000 | USD | 4 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001178913-25-001205 | 20231231 | Stock Issued During Period Value Treasury Stock Reissued | -638000.0000 | USD | 4 | us-gaap/2024 | Equity Components= Retained Earnings; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Increase Decrease In Accounts Payable Trade | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Trade | Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Interest Received | 0001178913-25-001205 | 1 | 0 | monetary | D | D | Interest Received | The amount of interest received. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Proceeds From Sale Of Treasury Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale of Treasury Stock | The cash inflow from the issuance of an equity stock that has been previously reacquired by the entity. |
| Restricted Cash Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Prepaid Expense Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Noncurrent | Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer. |
| Income Taxes Received | 0001178913-25-001205 | 1 | 0 | monetary | D | D | Income Taxes Received | It represents income taxes received. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock And Warrants Issued During Period Value New Issues | 0001178913-25-001205 | 1 | 0 | monetary | D | C | Stock And Warrants Issued During Period Value New Issues | Value of stock issued in lieu contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Accounts Payable Trade Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Trade, Current | Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Employee Related Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Stock And Warrants Issued During Period New Issues | 0001178913-25-001205 | 1 | 0 | shares | D | Stock And Warrants Issued During Period New Issues | it represents number of shares and warrants issued during period | |
| Common Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, No Par Value | Face amount per share of no-par value common stock. | |
| Deposits Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Deposits Assets, Current | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Noncurrent | Amount of obligation due after one year or beyond the normal operating cycle, if longer. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Value Treasury Stock Reissued | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Treasury Stock Reissued | Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Proceeds From Other Equity | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Other Equity | Amount of cash inflow from the issuance of equity classified as other. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares Treasury Stock Reissued | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Treasury Stock Reissued | Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement. | |
| Payments For Investment In Deposits | 0001178913-25-001205 | 1 | 0 | monetary | D | C | Payments for Investment in Deposits | The amount of payments for investm,ents in deposits. |
| Assets Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Noncurrent | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001178913-25-001205 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001178913-25-001205 | 4 | 5 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Financing income, net | 1 |
| 0001178913-25-001205 | 2 | 4 | BS | 0 | H | Deposits Assets Current | us-gaap/2024 | Short-term bank deposit | 0 |
| 0001178913-25-001205 | 2 | 5 | BS | 0 | H | Restricted Cash Current | us-gaap/2024 | Restricted cash | 0 |
| 0001178913-25-001205 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Other receivables and prepaid expenses | 0 |
| 0001178913-25-001205 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001178913-25-001205 | 2 | 9 | BS | 0 | H | Prepaid Expense Noncurrent | us-gaap/2024 | Long-term prepaid expenses | 0 |
| 0001178913-25-001205 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001178913-25-001205 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use assets | 0 |
| 0001178913-25-001205 | 2 | 12 | BS | 0 | H | Assets Noncurrent | us-gaap/2024 | Total non-current assets | 0 |
| 0001178913-25-001205 | 2 | 13 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001178913-25-001205 | 2 | 16 | BS | 0 | H | Accounts Payable Trade Current | us-gaap/2024 | Trade payables | 0 |
| 0001178913-25-001205 | 2 | 17 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001178913-25-001205 | 2 | 18 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Employee and related expenses | 0 |
| 0001178913-25-001205 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liabilities | 0 |
| 0001178913-25-001205 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001178913-25-001205 | 2 | 22 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Non-current operating lease liabilities | 0 |
| 0001178913-25-001205 | 2 | 23 | BS | 0 | H | Liabilities Noncurrent | us-gaap/2024 | Total non-current liabilities | 0 |
| 0001178913-25-001205 | 2 | 24 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingent liabilities | 0 |
| 0001178913-25-001205 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001178913-25-001205 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Ordinary Shares no par value - Authorized: 4,650,000,000 and 650,000,000 Ordinary shares as of December 31, 2024, and December 31, 2023, respectively (*) Issued and outstanding: 377,132,220, and 284,094,700 Ordinary shares of December 31, 2024 and 2023, respectively (*) | 0 |
| 0001178913-25-001205 | 2 | 28 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001178913-25-001205 | 2 | 29 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001178913-25-001205 | 2 | 30 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders' equity | 0 |
| 0001178913-25-001205 | 2 | 31 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0001178913-25-001205 | 3 | 1 | BS | 1 | H | Common Stock No Par Value | us-gaap/2024 | Common Stock, No Par Value | 0 |
| 0001178913-25-001205 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock, Shares Authorized | 0 |
| 0001178913-25-001205 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock, Shares, Issued | 0 |
| 0001178913-25-001205 | 3 | 4 | BS | 1 | H | Shares Outstanding | us-gaap/2024 | Common Stock, Shares, Outstanding | 0 |
| 0001178913-25-001205 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001178913-25-001205 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001178913-25-001205 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001178913-25-001205 | 4 | 6 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before taxes | 1 |
| 0001178913-25-001205 | 4 | 7 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Tax benefit | 0 |
| 0001178913-25-001205 | 4 | 8 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss for the year | 1 |
| 0001178913-25-001205 | 4 | 9 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic loss per Ordinary Share | 0 |
| 0001178913-25-001205 | 4 | 10 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted loss per Ordinary Share | 0 |
| 0001178913-25-001205 | 4 | 11 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of Ordinary Shares outstanding, basic | 0 |
| 0001178913-25-001205 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of Ordinary Shares outstanding, diluted | 0 |
| 0001178913-25-001205 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Beginning balance | 0 |
| 0001178913-25-001205 | 5 | 10 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Beginning balance (in shares) | 0 |
| 0001178913-25-001205 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001178913-25-001205 | 5 | 13 | EQ | 0 | H | Stock And Warrants Issued During Period Value New Issues | 0001178913-25-001205 | Issuance of shares and pre-funded warrants, net of issuance costs | 0 |
| 0001178913-25-001205 | 5 | 14 | EQ | 0 | H | Stock And Warrants Issued During Period New Issues | 0001178913-25-001205 | Issuance of shares and pre-funded warrants, net of issuance costs (in Shares) | 0 |
| 0001178913-25-001205 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of options | 0 |
| 0001178913-25-001205 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of options (in shares) | 0 |
| 0001178913-25-001205 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Treasury Stock Reissued | us-gaap/2024 | Sale of treasury share at cost | 0 |
| 0001178913-25-001205 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Treasury Stock Reissued | us-gaap/2024 | Sale of treasury share at cost (in shares) | 0 |
| 0001178913-25-001205 | 5 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0001178913-25-001205 | 5 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Ending balance | 0 |
| 0001178913-25-001205 | 5 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Ending balance (in shares) | 0 |
| 0001178913-25-001205 | 6 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss for the year | 0 |
| 0001178913-25-001205 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001178913-25-001205 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001178913-25-001205 | 6 | 6 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Change in other receivables and prepaid expenses | 1 |
| 0001178913-25-001205 | 6 | 7 | CF | 0 | H | Increase Decrease In Accounts Payable Trade | us-gaap/2024 | Change in trade payables | 0 |
| 0001178913-25-001205 | 6 | 8 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Change in accrued expenses | 0 |
| 0001178913-25-001205 | 6 | 9 | CF | 0 | H | Increase Decrease In Employee Related Liabilities | us-gaap/2024 | Change in employees and related expenses | 0 |
| 0001178913-25-001205 | 6 | 10 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Change in operating leases | 0 |
| 0001178913-25-001205 | 6 | 11 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001178913-25-001205 | 6 | 13 | CF | 0 | H | Payments For Investment In Deposits | 0001178913-25-001205 | Investment in deposits | 1 |
| 0001178913-25-001205 | 6 | 14 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001178913-25-001205 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash provided by investing activities | 0 |
| 0001178913-25-001205 | 6 | 17 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Exercise of options | 0 |
| 0001178913-25-001205 | 6 | 18 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Purchase of treasury share | 1 |
| 0001178913-25-001205 | 6 | 19 | CF | 0 | H | Proceeds From Sale Of Treasury Stock | us-gaap/2024 | Sale of treasury share | 0 |
| 0001178913-25-001205 | 6 | 20 | CF | 0 | H | Proceeds From Other Equity | us-gaap/2024 | Issuance of shares net of issuance costs | 0 |
| 0001178913-25-001205 | 6 | 21 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0001178913-25-001205 | 6 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Change in cash, cash equivalents and restricted cash | 0 |
| 0001178913-25-001205 | 6 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at beginning of the year | 0 |
| 0001178913-25-001205 | 6 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, cash equivalents and restricted cash at end of the year | 0 |
| 0001178913-25-001205 | 6 | 27 | CF | 0 | H | Income Taxes Received | 0001178913-25-001205 | Income taxes received | 0 |
| 0001178913-25-001205 | 6 | 28 | CF | 0 | H | Interest Received | 0001178913-25-001205 | Interest received | 0 |
| 0001178913-25-001205 | 6 | 30 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Right-of-use asset recognized with corresponding lease liability | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |